SCHEMBL5393249

SCHEMBL5393249

CCCCCCCCCCCCCC(=O)OS(=O)(=O)CCN

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.47
LMNA P02545 3/20 0.44
PAM P19021 2/20 0.43
MAPT P10636 3/20 0.42
MAPK1 P28482 1/20 0.42
TSHR P16473 2/20 0.41
ALDH1A1 P00352 3/20 0.41
THRB P10828 1/20 0.41
CNR1 P21554 1/20 0.41
CES2 O00748 3/20 0.41
CES1 P23141 3/20 0.41
DNM1 Q05193 1/20 0.40
NAAA Q02083 1/20 0.40
GPR84 Q9NQS5 2/20 0.39
PPARG P37231 2/20 0.39
PPARD Q03181 2/20 0.39
PPARA Q07869 2/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
SLC22A8 Q8TCC7 1/20 0.39
TLR2 O60603 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5156066 1.00 DGKA (0.47) DGKALMNAPAMMAPTMAPK1
SCHEMBL3634120 1.00 DGKA (0.47) DGKALMNAPAMMAPTMAPK1
SCHEMBL15874693 1.00 DGKA (0.47) DGKALMNAPAMMAPTMAPK1
SCHEMBL31051576 1.00 DGKA (0.47) DGKALMNAPAMMAPTMAPK1
SCHEMBL17085777 1.00 DGKA (0.47) DGKALMNAPAMMAPTMAPK1
SCHEMBL1982508 0.98 DGKA (0.46) DGKALMNAPAMMAPTMAPK1
SCHEMBL1987495 0.98 DGKA (0.46) DGKALMNAPAMMAPTMAPK1
SCHEMBL22325614 0.98 DGKA (0.46) DGKALMNAPAMMAPTMAPK1
Potassium SCHEMBL31028519 0.98 DGKA (0.46) DGKALMNAPAMMAPTMAPK1
SCHEMBL22325596 0.98 DGKA (0.46) DGKALMNAPAMMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676436-A1 PERSONAL CARE COMPOSITION The Procter & Gamble Company (US) 2026-01-14 EP claimed
EP-4676435-A1 PERSONAL CARE COMPOSITION The Procter & Gamble Company (US) 2026-01-14 EP claimed
US-20240299285-A1 PERSONAL CARE COMPOSITION THE PROCTER & GAMBLE COMPANY 2024-09-12 US claimed
WO-2024187075-A1 PERSONAL CARE COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2024-09-12 WO claimed
WO-2024187076-A1 PERSONAL CARE COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2024-09-12 WO claimed
US-20240299272-A1 PERSONAL CARE COMPOSITION THE PROCTER & GAMBLE COMPANY 2024-09-12 US claimed
EP-3551162-B1 COMPOSITION SUITABLE FOR CLEANSING OREAL (FR) 2024-06-26 EP claimed
EP-4731176-A1 COMPOSITION COMPRISING GLYCOLIPID, TAURATE SURFACTANT, AND AMINO ACID SURFACTANT L'OREAL (FR) 2026-04-29 EP disclosed
EP-4731173-A1 COMPOSITION COMPRISING LOW MOLECULAR WEIGHT POLYLYSINE AND GLYCOLIPIDS L'OREAL (FR) 2026-04-29 EP disclosed
US-20260076887-A1 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS PROCTER & GAMBLE (US) 2026-03-19 US disclosed
US-20260062648-A1 Dissolvable Solid Cleansing Articles Containing Taurate Surfactants PROCTER & GAMBLE (US) 2026-03-05 US disclosed
US-12559611-B2 Hydrophobic alginic acid particle group and method for producing same NISSHINBO HOLDINGS INC. (JP) 2026-02-24 US disclosed
EP-4676435-A1 PERSONAL CARE COMPOSITION The Procter & Gamble Company (US) 2026-01-14 EP disclosed
CN-103702656-B Shampoo compositions SHISEIDO CO.,LTD. (JP) 2015-09-30 CN disclosed
CN-103702656-A Shampoo compositions SHISEIDO CO LTD 2014-04-02 CN disclosed
US-20140086864-A1 Shampoo Compostion SHISEIDO COMPANY, LTD. (JP) 2014-03-27 US disclosed
CN-103619315-A Toothpaste substance for dentine hypersensitivity KAO CORP 2014-03-05 CN disclosed
US-7166136-B2 Stability and dyeability, which provides excellent sensation upon use (smoothness), and which can be easily rinsed off after use SHISEIDO COMPANY, LTD. (JP) 2007-01-23 US disclosed
US-20050071931-A1 Hairdye preparation SHISEIDO COMPANY, LTD. (JP) 2005-04-07 US disclosed
US-4212966-A AGITATING MELT WITH SURFACTANT TO FORM DISPERSION NATIONAL DISTILLERS & CHEMICAL CORPORATION (US) 1980-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140086864-A1 Shampoo Compostion TAAR5, PHOSPHO1, SGMS2 DGKA 1091/4885LMNA 1836/4885PAM 1579/4885
US-20050071931-A1 Hairdye preparation CD44, SCN7A, CUTA DGKA 591/4885LMNA 1401/4885PAM 3734/4885
US-20240299272-A1 PERSONAL CARE COMPOSITION TAF1, POLH, KAT7 DGKA 2670/4885LMNA 1353/4885PAM 2267/4885
US-20260062648-A1 Dissolvable Solid Cleansing Articles Containing Taurate Surfactants SLC6A6, PHOSPHO1, SGMS2 DGKA 222/4885LMNA 1147/4885PAM 4356/4885
US-20260076887-A1 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS CUTA, PHOSPHO1, MGLL DGKA 2226/4885LMNA 2819/4885PAM 2814/4885
US-20240299285-A1 PERSONAL CARE COMPOSITION KAT7, SMURF1, CUTA DGKA 2070/4885LMNA 2202/4885PAM 3662/4885
US-12559611-B2 Hydrophobic alginic acid particle group and method for producing same ALG3, ALG1, HACD3 DGKA 2468/4885LMNA 2642/4885PAM 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.